The Novel Innovations for Tissue Regeneration in Osteoarthritis will explore ways to help the human body repair its own joints, according to a May 18 news release. Under the program, NITRO will explore technologies in three areas: injectable bone regeneration, injectable cartilage regeneration and replacement joints made from human cells.
The program is the first program under the ARPA-H.
